Literature DB >> 15047755

CD20 positive T cell lymphoma: is it a real entity?

T Sun1, A Akalin, M Rodacker, T Braun.   

Abstract

CD20+ T cell lymphoma is a rare condition that includes both precursor and peripheral T cell types. However, these cases may be mistaken for T cell marker positive B cell lymphoma, thus creating diagnostic problems with subsequent clinical implications. This report describes a unique case of nodal CD20+ T cell lymphoma with simultaneous cutaneous and subcutaneous involvement. Both nodal and cutaneous lymphomas demonstrated identical monoclonal bands in the T cell receptor rearrangement assay. However, no CD20 expression was demonstrated in the skin lesion. The instability of the CD20 antigen in this tumour may imply that CD20 is not an integral part of the tumour immunophenotype and probably plays no important role in its clinical course. Techniques to avoid misdiagnosis of this lymphoma are discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15047755      PMCID: PMC1770255          DOI: 10.1136/jcp.2003.011734

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Peripheral T-cell lymphoma with aberrant expression of CD79a and CD20: a diagnostic pitfall.

Authors:  X Yao; J Teruya-Feldstein; M Raffeld; L Sorbara; E S Jaffe
Journal:  Mod Pathol       Date:  2001-02       Impact factor: 7.842

Review 2.  CD20-Positive peripheral T-cell lymphoma: report of a case after nodular sclerosis Hodgkin's disease and review of the literature.

Authors:  R L Mohrmann; D A Arber
Journal:  Mod Pathol       Date:  2000-11       Impact factor: 7.842

3.  Immunoreactivity of B-cell markers (CD79a, L26) in rare cases of extranodal cytotoxic peripheral T- (NK/T-) cell lymphomas.

Authors:  K Blakolmer; M Vesely; J A Kummer; W Jurecka; C Mannhalter; A Chott
Journal:  Mod Pathol       Date:  2000-07       Impact factor: 7.842

4.  CD20 (pan-B cell antigen) expression on bone marrow-derived T cells.

Authors:  K M Algino; R W Thomason; D E King; M M Montiel; F E Craig
Journal:  Am J Clin Pathol       Date:  1996-07       Impact factor: 2.493

5.  B cell associated monoclonal antibody L26 may occasionally label T cell lymphomas.

Authors:  S J Hamilton-Dutoit; G Pallesen
Journal:  APMIS       Date:  1989-11       Impact factor: 3.205

6.  Immunophenotypic variability of B-cell non-Hodgkin lymphoma: a retrospective study of cases analyzed by flow cytometry.

Authors:  Carolina Echeverri; Stephen Fisher; David King; Fiona E Craig
Journal:  Am J Clin Pathol       Date:  2002-04       Impact factor: 2.493

7.  CD20 (pan-B cell) antigen is expressed at a low level on a subpopulation of human T lymphocytes.

Authors:  L E Hultin; M A Hausner; P M Hultin; J V Giorgi
Journal:  Cytometry       Date:  1993

8.  CD20-positive T-cell chronic lymphocytic leukaemia.

Authors:  A Takami; M Saito; S Nakao; H Asakura; T Nozue; Y Onoe; A Yachie; S Shiobara; T Matsuda
Journal:  Br J Haematol       Date:  1998-09       Impact factor: 6.998

9.  CD20+ T-cell lymphoma. Neoplastic transformation of a normal T-cell subset.

Authors:  L Quintanilla-Martinez; F Preffer; D Rubin; J A Ferry; N L Harris
Journal:  Am J Clin Pathol       Date:  1994-10       Impact factor: 2.493

10.  Low level CD20 expression on T cell malignancies.

Authors:  M J Warzynski; D M Graham; R A Axtell; M H Zakem; R K Rotman
Journal:  Cytometry       Date:  1994-06-15
  10 in total
  9 in total

1.  Novel CD19 expression in a peripheral T cell lymphoma: A flow cytometry case report with morphologic correlation.

Authors:  Kathryn Rizzo; Maryalice Stetler-Stevenson; Wyndham Wilson; Constance M Yuan
Journal:  Cytometry B Clin Cytom       Date:  2009-03       Impact factor: 3.058

Review 2.  Primary T cell central nervous system lymphoblastic lymphoma in a child: case report and literature review.

Authors:  Marcus D Mazur; Vijay M Ravindra; Mouied Alashari; Elizabeth Raetz; Matthew M Poppe; Robert J Bollo
Journal:  Childs Nerv Syst       Date:  2015-02-15       Impact factor: 1.475

Review 3.  CD20+ T cells: an emerging T cell subset in human pathology.

Authors:  Adrian Y S Lee
Journal:  Inflamm Res       Date:  2022-08-11       Impact factor: 6.986

Review 4.  CD20-positive primary gastric T-cell lymphoma poorly responding to initial treatment with rituximab plus CHOP, and a literature review.

Authors:  Yasutaka Kakinoki; Junichi Hashiguchi; Takashi Ishio; Koji Chiba; Daisuke Niino; Koichi Ohshima
Journal:  Int J Hematol       Date:  2015-08-07       Impact factor: 2.490

5.  Localized nasal cavity, sinus, and massive bilateral orbital involvement by human T cell leukemia virus 1 adult T cell lymphoma, with epidermal hypertrophy due to mite infestation.

Authors:  Kathleen Laveaux; Constantine A Axiotis; Helen Durkin; Albert S Braverman
Journal:  Rare Tumors       Date:  2010-12-31

6.  CD20 Positive T Cell Lymphoma Involvement of Skin.

Authors:  Ki Yeol Lee; Su Young Jeon; Jin Woo Hong; Young Hun Kim; Ki Hoon Song; Ki Ho Kim
Journal:  Ann Dermatol       Date:  2011-11-03       Impact factor: 1.444

7.  Level of PAX5 in differential diagnosis of non-Hodgkin's lymphoma.

Authors:  Brij Bharti; Sachin Shukla; Ratnakar Tripathi; Suman Mishra; Mohan Kumar; Manoj Pandey; Rajnikant Mishra
Journal:  Indian J Med Res       Date:  2016-05       Impact factor: 2.375

8.  MR Imaging Characteristics of Primary T-Cell Lymphoma of the Cauda Equina: A Case Report and Literature Review.

Authors:  Younguk Kim; Guen Young Lee; Sujin Kim; Kwang-Sup Song; Hee Sung Kim
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2021-10-18

Review 9.  CD20-positive NK/T-cell lymphoma with indolent clinical course: report of case and review of literature.

Authors:  Qing-ping Jiang; Shao-yan Liu; Yue-xin Yang; Xue-xian Tan; Juan Peng; Zhong-tang Xiong; Zhi Li
Journal:  Diagn Pathol       Date:  2012-10-02       Impact factor: 2.644

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.